Seagen (SGEN) PT Lowered to $146 at Wolfe Research
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Seagen (SGEN) Stock Plunges on Weak Outlook and Q4 Miss, Analysts Lower Price Targets
February 10, 2022 7:14 AM ESTShares of Seagen (NASDAQ: SGEN) plummeted more than 16.5% in premarket trading on Thursday after the biotech company reported Q4 2021 and FY 2021 financial results.
The company reported that Q4 revenue climbed to $369.2 million, down from $601.3 million in the year-ago period. FY 2021 revenue came in at $1.57 billion, way below $2.17 billion reported in Q4 2020. Analysts were calling for Q4 EPS of ($0.82) on sales of $406.87 million.
Seagen sees 2022 revenue of $1.48-1.545 billion, versus the consensus of $2.16 billion.
Total net product... More
Seagen (SGEN) PT Lowered to $170 at H.C. Wainwright
February 10, 2022 6:40 AM ESTH.C. Wainwright analyst Andrew Fein lowered the price target on Seagen (NASDAQ: SGEN) to $170.00 (from $200.00) while maintaining a Buy rating following results.
The analyst commented, "Yesterday, Seagen delivered revenue guidance which fell below consensus estimates suggestive of incremental to flat sales growth... More
